clinical trial · NCT02425644
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Actelion·phase3·completed·n = 1,133
Multiple Sclerosisponesimodteriflunomide
brief summary
International clinical trial to compare ponesimod and teriflunomide in relapsing multiple sclerosis
started
Jun 4, 2015
primary completion
May 16, 2019
completion
May 16, 2019
last updated
Mar 30, 2025
official title
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol